Literature DB >> 32109962

For Primary Prevention, Should All Moderate- to High-Risk Patients Be Considered Candidates for Acetylsalicylic Acid?

.   

Abstract

Entities:  

Year:  2020        PMID： 32109962      PMCID： PMC7023933     

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  36 in total

1.  GRACE score predicts heart failure admission following acute coronary syndrome.

Authors:  David A McAllister; Nynke Halbesma; Kathryn Carruthers; Martin Denvir; Keith A Fox
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2014-07-01

2.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

Authors:  Yongjun Wang; Yilong Wang; Xingquan Zhao; Liping Liu; David Wang; Chunxue Wang; Chen Wang; Hao Li; Xia Meng; Liying Cui; Jianping Jia; Qiang Dong; Anding Xu; Jinsheng Zeng; Yansheng Li; Zhimin Wang; Haiqin Xia; S Claiborne Johnston
Journal:  N Engl J Med       Date:  2013-06-26       Impact factor: 91.245

3.  Prognosis in intracerebral hemorrhage.

Authors:  Kenneth M Crandall; Natalia S Rost; Kevin N Sheth
Journal:  Rev Neurol Dis       Date:  2011

4.  Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.

Authors:  Renato D Lopes; Hwanhee Hong; Ralf E Harskamp; Deepak L Bhatt; Roxana Mehran; Christopher P Cannon; Christopher B Granger; Freek W A Verheugt; Jianghao Li; Jurriën M Ten Berg; Nikolaus Sarafoff; C Michael Gibson; John H Alexander
Journal:  JAMA Cardiol       Date:  2019-08-01       Impact factor: 14.676

Review 5.  Management of antiphospholipid syndrome.

Authors:  Imad Uthman; Mohammad Hassan A Noureldine; Guillermo Ruiz-Irastorza; Munther Khamashta
Journal:  Ann Rheum Dis       Date:  2018-10-03       Impact factor: 19.103

6.  Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.

Authors:  Pascal Vranckx; Marco Valgimigli; Lars Eckardt; Jan Tijssen; Thorsten Lewalter; Giuseppe Gargiulo; Valerii Batushkin; Gianluca Campo; Zoreslava Lysak; Igor Vakaliuk; Krzysztof Milewski; Petra Laeis; Paul-Egbert Reimitz; Rüdiger Smolnik; Wolfgang Zierhut; Andreas Goette
Journal:  Lancet       Date:  2019-09-03       Impact factor: 79.321

7.  Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.

Authors:  John J McNeil; Rory Wolfe; Robyn L Woods; Andrew M Tonkin; Geoffrey A Donnan; Mark R Nelson; Christopher M Reid; Jessica E Lockery; Brenda Kirpach; Elsdon Storey; Raj C Shah; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Colin I Johnston; Joanne Ryan; Barbara Radziszewska; Michael Jelinek; Mobin Malik; Charles B Eaton; Donna Brauer; Geoff Cloud; Erica M Wood; Suzanne E Mahady; Suzanne Satterfield; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

8.  Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.

Authors:  John J McNeil; Mark R Nelson; Robyn L Woods; Jessica E Lockery; Rory Wolfe; Christopher M Reid; Brenda Kirpach; Raj C Shah; Diane G Ives; Elsdon Storey; Joanne Ryan; Andrew M Tonkin; Anne B Newman; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Geoffrey A Donnan; Peter Gibbs; Colin I Johnston; Barbara Radziszewska; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

9.  Online decision aids for primary cardiovascular disease prevention: systematic search, evaluation of quality and suitability for low health literacy patients.

Authors:  Carissa Bonner; Pinika Patel; Michael Anthony Fajardo; Ruixuan Zhuang; Lyndal Trevena
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

10.  Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility.

Authors:  Marianna Fontana; Perviz Asaria; Michela Moraldo; Judith Finegold; Khalil Hassanally; Charlotte H Manisty; Darrel P Francis
Journal:  Circulation       Date:  2014-04-17       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.